コーパス検索結果 (１語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 al analog pain scale of the Multidimensional Health Assessment Questionnaire.
2 nd on functional outcome, as assessed by the Health Assessment Questionnaire.
3 were collected by using a modified Stanford Health Assessment Questionnaire.
4 come data collected included the Scleroderma Health Assessment Questionnaire.
5 ation of hand function using the Scleroderma Health Assessment Questionnaire.
6 tion rate 33 mm/hour versus 20, and modified Health Assessment Questionnaire 1.0 versus 0.4 (P < 0.01
7 daily living (ADL) question of the Modified Health Assessment Questionnaire; a question about the du
8 udinal outcome study by mailed comprehensive Health Assessment Questionnaire administered every 6 mon
9 Rodnan skin thickness score and the modified Health Assessment Questionnaire after 12 months of oral
10 , the cross-cultural adaptation of the Child Health Assessment Questionnaire and the Child Health Que
11 omic issues and functional status (using the Health Assessment Questionnaire and the Health Status Qu
12 tive patients were followed up with biannual Health Assessment Questionnaires and medical record audi
13 Cumulative disability was determined with a health-assessment questionnaire and scored on a scale of
14 es, QOL as measured by the Short Form 36 and Health Assessment Questionnaire, and diagnosis reassessm
15 ional disability as measured by the modified Health Assessment Questionnaire, and erythrocyte sedimen
16 alog scales for pain and general health, the Health Assessment Questionnaire, and erythrocyte sedimen
17 ry measurements were pulmonary function, the Health Assessment Questionnaire, and other measures of s
18 patient's global assessments, ESR, modified Health Assessment Questionnaire, and patient's pain asse
19 nd stiffness of the target joint, a modified Health Assessment Questionnaire, and the EuroQol 5-domai
20 aversion-Openness Personality Inventory, the Health Assessment Questionnaire, and the Psychosocial Ad
21 skin thickness score (MRSS), the Scleroderma Health Assessment Questionnaire, assessment of organ-bas
23 28-joint Disease Activity Score (P = 0.023), health assessment questionnaire disability (P = 0.05), t
24 modified Rodnan skin thickness score (MRSS), Health Assessment Questionnaire disability index (HAQ DI
25 6; DAS28-4(ESR)-defined remission, change in Health Assessment Questionnaire Disability Index (HAQ-DI
26 s (P = 0.0119), handspread (P = 0.0242), and Health Assessment Questionnaire disability index (HAQ-DI
28 by modified Rodnan skin scores and modified health assessment questionnaire disability index (mHAQ-D
29 physical function according to scores on the Health Assessment Questionnaire Disability Index (odds r
30 had at least 0.5 units of improvement in the Health Assessment Questionnaire disability index (P < 0.
31 yment status, and functional disability (the Health Assessment Questionnaire disability index [HAQ DI
32 f-reported physical function status with the Health Assessment Questionnaire Disability Index and ass
33 actor of 3 with each 1-point increase in the Health Assessment Questionnaire disability index modifie
35 08; P < .001) and overall function (modified Health Assessment Questionnaire Disability Index, -1.03;
36 , ACR50, and ACR70 responses, scores for the Health Assessment Questionnaire disability index, the 3-
37 ypes, baseline log C-reactive protein level, Health Assessment Questionnaire Disability Index, total
39 Patients with highly abnormal values on the Health Assessment Questionnaire Disability Scale, global
41 month 3 and the change from baseline in the Health Assessment Questionnaire-Disability Index (HAQ-DI
42 e) and the change from baseline score on the Health Assessment Questionnaire-Disability Index (HAQ-DI
43 scale (ACR 20), the change from baseline in Health Assessment Questionnaire-Disability Index (HAQ-DI
44 from baseline to month 3 in the score on the Health Assessment Questionnaire-Disability Index (HAQ-DI
45 0% (ACR20) response (primary end point), the Health Assessment Questionnaire-Disability Index (HAQ-DI
46 including function measured by the modified Health Assessment Questionnaire, disease activity measur
47 ile of functional status, as measured by the Health Assessment Questionnaire, experienced direct medi
48 er scores indicate more limitations) and the Health Assessment Questionnaire for the Spondylarthropat
50 , scored in a manner similar to that for the Health Assessment Questionnaire (HAQ) (range 0-3), were
51 Physical functioning was assessed using the Health Assessment Questionnaire (HAQ) and clinical respo
52 sion, osteitis, and synovitis, scores on the Health Assessment Questionnaire (HAQ) and the Short Form
53 neric health status/QOL were assessed by the Health Assessment Questionnaire (HAQ) and the Short Form
54 is (RA) by using the disability index of the Health Assessment Questionnaire (HAQ) as the measure of
56 imal improvements evident at 6 months in the Health Assessment Questionnaire (HAQ) disability index (
58 The course of changes in lung function, the Health Assessment Questionnaire (HAQ) disability index (
59 epression Scale (CES-D; range 0-60), and the Health Assessment Questionnaire (HAQ) disability index (
60 Physical function was assessed using the Health Assessment Questionnaire (HAQ) disability index (
61 ealth status: the Short Form 36 (SF-36), the Health Assessment Questionnaire (HAQ) disability index (
62 f Chronic Illness Therapy-Fatigue (FACIT-F), Health Assessment Questionnaire (HAQ) Disability Index (
64 Study Short Form 36 (SF-36) and the Stanford Health Assessment Questionnaire (HAQ) Disability Index (
65 rm 36 (SF-36) modified health survey and the Health Assessment Questionnaire (HAQ) disability index a
66 tudy Short Form 36 (MOS SF-36), and Stanford Health Assessment Questionnaire (HAQ) Disability Index a
68 l disability, as reflected by scores for the Health Assessment Questionnaire (HAQ) disability index,
69 of skin disease (r = 0.69, P < 0.0001), and Health Assessment Questionnaire (HAQ) disability scores
72 tology classification criteria for RA, had a Health Assessment Questionnaire (HAQ) score collected, a
75 ine and the swollen and tender joint counts, Health Assessment Questionnaire (HAQ) scores, C-reactive
76 oms, examination of inflamed joints, and the Health Assessment Questionnaire (HAQ) were the main meas
78 nalog scale), physical function score on the Health Assessment Questionnaire (HAQ), and levels of an
79 radiographs, functional evaluation using the Health Assessment Questionnaire (HAQ), and quality of li
80 assessed using the following tools: QWB-SA, Health Assessment Questionnaire (HAQ), Arthritis Impact
81 st, Fibromyalgia Impact Questionnaire (FIQ), Health Assessment Questionnaire (HAQ), Short Form Health
82 ulcers and infarcts; patients completed the Health Assessment Questionnaire (HAQ), the Arthritis Imp
83 Survey (SF-36), the disability index of the Health Assessment Questionnaire (HAQ), the Nail Psoriasi
84 d physical performance, as measured with the Health Assessment Questionnaire (HAQ), the Valued Life A
85 lean mass with disability, measured with the Health Assessment Questionnaire (HAQ), were explored for
86 Functional ability was assessed using the Health Assessment Questionnaire (HAQ), with adjustment f
91 es included the disability index (DI) of the Health Assessment Questionnaire (HAQ); Disease Activity
93 as their physical function (according to the Health Assessment Questionnaire [HAQ] disability index [
95 utcomes included disease activity, function (Health Assessment Questionnaire [HAQ] score), and RA qua
96 ing QOL (Short Form 36 [SF-36]), disability (Health Assessment Questionnaire [HAQ]), and mood (Hospit
98 Larsen method), functional assessment by the Health Assessment Questionnaire, history of joint surger
99 d assessments of daily functioning (Stanford Health Assessment Questionnaire, Lawton Instrumental Act
100 Disability was measured with the modified Health Assessment Questionnaire (M-HAQ) and the physical
101 tive patients with RA completed the modified Health Assessment Questionnaire (M-HAQ) and the Short Fo
103 ologic Studies Depression Scale and Modified Health Assessment Questionnaire (M-HAQ) scores, demograp
104 ct Questionnaire (FIQ), the Multidimensional Health Assessment Questionnaire (MDHAQ), the pain improv
105 ng self-report questionnaires: HAP, Modified Health Assessment Questionnaire, Medical Outcomes Study
106 self-report joint counts, function (modified Health Assessment Questionnaire [mHAQ]), self efficacy,
107 mes included CR at weeks 4 and 12, function (Health Assessment Questionnaire), pain (0-100-mm visual
109 llowup evaluations with use of the Childhood Health Assessment Questionnaire, physician global assess
110 = -0.57 for Sharp's score), and the Modified Health Assessment Questionnaire (r = 0.38 for NDJ, and r
112 of 152), and functional disability by Child Health Assessment Questionnaire score >0 (53 [68%] of 11
113 sus 5.1), and had greater disability (median Health Assessment Questionnaire score 2.1 versus 1.6).
116 dels, age at onset, male sex, RF positivity, Health Assessment Questionnaire score>or=1.5, and nodule
117 rction, low-dose aspirin, comorbidity score, Health Assessment Questionnaire score, and presence of t
118 did not predict SRC included age, sex, race, Health Assessment Questionnaire score, fist closure, han
119 int disease activity score (DAS28), baseline health assessment questionnaire score, gender and concur
120 rivation Index were also predictive, but the Health Assessment Questionnaire score, rheumatoid factor
121 rheumatoid factor, nodular disease, modified Health Assessment Questionnaire score, taking CVD drugs,
122 linically important improvements in modified Health Assessment Questionnaire scores compared with pat
123 fter 2 years, significant differences in the Health Assessment Questionnaire scores remained, but the
124 ssment of disease activity, and the modified Health Assessment Questionnaire scores were collected.
126 from baseline in the disability index of the Health Assessment Questionnaire showed greater decreases
127 ical component sections of the Short-Form 36 Health Assessment Questionnaire than did antibiotic-trea
128 mal clinically important difference of Child Health Assessment Questionnaire, the cross-cultural adap
130 ty in the DAS and other RA scales (e.g., the Health Assessment Questionnaire) to recommend them as so
131 amble technique [SG]), disability (Childhood Health Assessment Questionnaire), VAS of pain, and VAS o
132 , physician global disease rating, Childhood Health Assessment Questionnaire); visits (PV = 941) with
135 owing infliximab therapy, measured using the Health Assessment Questionnaire, was significantly assoc
136 e, and functional ability as measured by the Health Assessment Questionnaire were determined before a
138 y, the swollen joint count, and function (by Health Assessment Questionnaire) were all significantly
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。